Benchmark Downgrades Regeneron Pharma (REGN) to Hold

November 5, 2021 6:24 AM

Benchmark analyst Aydin Huseynov downgraded Regeneron Pharma (NASDAQ: REGN) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found